Biotechnology Stocks I Performance Guide: Spyre Therapeutics, Inc. (SYRE)
SYRE has no dividends.
Table and Chart of SYRE Performance
See what a $1,000 investment in SYRE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SYRE Returns | |
|---|---|
| Start Date | May-31-2016 |
| Start Price | $187.50 |
| End Date | Oct-11-2024 |
| End Price | $28.70 |
| # Prices | 102 |
| Min Date | May-31-2023 |
| Min Price | $3.25 |
| Max Date | Aug-31-2018 |
| Max Price | $273.25 |
| Total Return | -84.69% |
| Annualized Return | -19.81% |
| Current Value of $1,000 Purchase | $153 |
| Number Returns | 5,151 |
| Average Return | -22.47% |
| Number Profitable Returns | 1,632 |
| Percent Profitable Returns | 31.68% |
| Number Unprofitable Returns | 3,519 |
| Percent Unprofitable Returns | 68.32% |
| Profitable to Unprofitable Returns Ratio | 0.46 |
| SYRE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -7.960 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -172547008 |
| PE to Growth Ratio | 2.635 |
| Price to Book | 2209.92 |
| PRICE DATA | |
| 52 Week High | $2.926 |
| 52 Week Low | $47.97 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $8.43 |
| 200-Day Moving Average | $27.53 |
| FINANCIAL DATA | |
| Revenue per Share | $10.89 |
| Revenue | $-1 |
| Profit Margin | 0% |
| Return on Equity | -31.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SYRE Compare Returns with S&P 500
SYRE Trendline Chart
SYRE Moving Average Chart
SYRE Stock Return Map - See Patterns of Gains and Losses
SYRE Stock Returns/Purchase Dates